Monitoring high potassium with a smart ECG device in kidney disease
Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests if a portable ECG device can help detect high potassium levels early in people with moderate to severe chronic kidney disease. It aims to make monitoring easier without frequent blood tests.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have chronic kidney disease stage 3b, 4, or 5 (your kidney function is moderately to severely reduced).
- You visit your kidney doctor at least once every three months.
- You agree to use the study device and sign a consent form.
- You are not currently on dialysis or expected to need it within the next 6 months.
- You do not have a pacemaker.
- You are able and willing to use the ECG device as instructed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares the effectiveness and resource use of remote patient monitoring across different dialysis methods for people with end-stage renal disease. It aims to see if remote monitoring can improve care and outcomes.
This study tests if a device can accurately measure potassium levels in people with chronic kidney disease. It also uses an iPhone app to monitor patients remotely.
This study looks at how common high potassium levels are in people with chronic kidney disease who are not on dialysis. It may help find who is at risk and how to prevent it.
This study looks at how high potassium levels (hyperkalemia) in people with chronic kidney disease may affect the heart. Doctors will use echocardiograms (heart ultrasounds) to check for changes.
This study tests whether using a home blood pressure monitoring device and phone-based check-ins can help people with high blood pressure and chronic kidney disease manage their health better. You may be asked to record readings and send them regularly during the study.
This study uses AI to look at your ECG and decide the best time to give treatment for high potassium (levels over 5.5). It aims to find the most effective timing to lower potassium safely in the emergency room.
Hear when a new Chronic Kidney Disease (Stages 3b-5) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.